INTRODUÇÃO: A intervenção coronária percutânea (ICP) em lesões ostiais é um dos maiores desafios para a cardiologia intervencionista contemporânea. A despeito dos avanços tecnológicos, as lesões ostiais ainda apresentam maiores taxas de eventos adversos imediatos e tardios quando comparadas às lesões não-ostiais. O objetivo deste estudo foi avaliar a ICP em lesões ostiais, utilizando a técnica de Szabo. MÉTODOS: Série de 10 pacientes, incluídos entre outubro e novembro de 2011, tratados por meio de ICP utilizando a técnica de Szabo em lesões ostiais em ramos coronários principais. Não foram abordadas lesões aorto-ostiais. RESULTADOS: Dos 10 pacientes tratados, 7 eram do sexo masculino, com idade variando entre 42 anos e 75 anos, e 60% apresentavam síndrome coronária aguda sem supradesnivelamento do segmento ST. Artéria circunflexa foi tratada em 6 pacientes e cateter 7 F foi utilizado em 8 pacientes. Em 3 pacientes não se observou progressão do stent em decorrência de torção das cordas-guia, que foi resolvida com o recuo parcial da corda-guia direcionada para a lesão-alvo e novo posicionamento. Houve sucesso do procedimento em 90% dos casos. Não ocorreram óbitos, (re)infartos ou revascularizações de urgência hospitalares. CONCLUSÕES: Neste estudo, a técnica de Szabo permitiu tratar lesões ostiais em ramos principais das artérias coronárias com sucesso, posicionando o stent de maneira adequada na maioria dos casos.

BACKGROUND:Percutaneous coronary intervention (PCI) in ostial lesions is one of the major challenges for contemporary interventional cardiology. Despite the technological advances, ostial lesions still present a higher rate of immediate and late adverse events when compared to non-ostial lesions. The objective of this study was to evaluate coronary ostial lesions treated with the Szabo technique. METHODS: Series of 10 patients, included between October and November 2011, treated by PCI using the Szabo technique to treat ostial lesions in main coronary arteries. Aorto-ostial lesions were excluded. RESULTS: Of the 10 patients treated, 7 were male, with ages ranging from 42 to 75 years and 60% had acute coronary syndromes without ST-segment elevation. The circumflex artery was treated in 6 patients and a 7 F catheter was used in 8 patients. In 3 patients, during the advancement of the stent to the lesion, both guidewires twisted, which was solved by partially retrieving the standard target vessel wire and positioning it again. Procedural success was observed in 90% of the cases. There were no hospital deaths, (re)infarctions or emergency revascularizations. CONCLUSIONS: In this study, the Szabo technique successfully treated ostial lesions in main coronary arteries, providing adequate positioning of the stent in most of the cases.

INTRODUÇÃO: Dados preliminares têm demonstrado que o perfil de segurança e eficácia do stent Firebird™ é semelhante ao do stent Cypher®. No entanto, até o presente momento, nenhum estudo avaliou a intervenção coronária percutânea (ICP) com o Firebird™ em diabéticos. MÉTODOS: Comparamos, em diabéticos portadores de doença arterial coronária (DAC) multiarterial, o desempenho do Firebird™ (n = 100) ao do Cypher®, utilizando os dados históricos do estudo ARTS-II (n = 159). Foram comparados os eventos cardiovasculares adversos maiores (ECAM) em um ano. RESULTADOS: A maioria dos pacientes do grupo Firebird™ era do sexo masculino (65%), com média de idade de 63,3 ± 10,4 anos e 5% estavam em uso de insulina. Predominaram os quadros clínicos estáveis (60%), 45% eram portadores de DAC triarterial e a função ventricular era preservada (56,6 ± 13,7%). Nos pacientes com DAC triarterial, foram tratadas 135 lesões, com 3 ou mais stents em 78% dos casos e 2 stents nos demais. Nos pacientes com DAC biarterial, foram tratadas 110 lesões com 2 ou mais stents em 80% dos casos e 1 stent nos demais. A incidência de ECAM em um ano do Firebird™ foi de 21%, óbito ocorreu em 3% dos pacientes, infarto do miocárdio em 2%, e novo procedimento de revascularização miocárdica em 18%, predominantemente à custa de nova ICP em 14% dos casos. A comparação com o grupo Cypher® não mostrou diferenças para nenhum dos desfechos avaliados. CONCLUSÕES: Em nosso estudo, o uso do stent Firebird™ apresentou resultados similares aos dos pacientes do estudo ARTS-II, o que o torna atrativo para ser utilizado no complexo cenário de pacientes diabéticos portadores de DAC multiarterial.

BACKGROUND: Preliminary data have shown the Firebird™ and the Cypher® stents have similar safety and efficacy profiles. However, to date, no study has evaluated the percutaneous coronary intervention (PCI) with the Firebird™ stent in diabetic patients. METHODS: The performance of the Firebird™ stent in diabetic patients with multivessel coronary artery disease (CAD) (n = 100) was compared to that of the Cypher® stent, using historical data from the ARTS-II study (n = 159). We compared the major adverse cardiovascular events (MACE) at one year. RESULTS: Most of the patients in the Firebird™ group were male (65%), with mean age of 63.3 ± 10.4 years and 5% were receiving insulin. Stable coronary syndromes were prevalent (60%), 45% had three-vessel CAD and ventricular function was preserved (56.6 ± 13.7%). In patients with three-vessel CAD, 135 lesions were treated with > 3 stents in 78% of the cases and 2 stents in the remaining ones. In patients with two-vessel CAD, 110 lesions were treated with > 2 stents in 80% of the cases and 1 stent in the remaining ones. The incidence of MACE at one year of the Firebird™ stent was 21%, death was observed in 3% of the patients, myocardial infarction in 2% and a new revascularization procedure in 18%, predominantly at the expense of a new PCI in 14% of the cases. Comparison with the Cypher® group did not show differences for any of the evaluated endpoints. CONCLUSIONS: In our study, the use of the Firebird™ stent showed similar results to those of patients in the ARTS-II study, which makes it attractive for use in the complex scenario of diabetic patients with multivessel CAD.

Prader- Willi syndrome is an uncommon multisystem genetic disorder caused by defects of chromosome 15 (15qll-ql3), often due to deletions or uniparental disomy The syndrome is characterized by neonatal hypotonia, dysmorphic facial features, short stature, motor and mental disabilities, behavioral changes, hyperphagia, precocious obesity and hypogonadotropic hypogonadism. We present a 17year-old woman, with a previous genetic diagnosis of Prader-Willi syndrome and BMI of 74 Kg/m², that was admitted in anasarca, with marked cyanosis, dyspnea and oliguria. She presented high levels ofblood urea, creatinine and aminotransferases, in addition to hyperkalemia and hyperuricemia. She had been in regular use of fluoxetine during the last six months, and evolved with severe high bloodpressure and respiratory failure, which needed intensive care support. Moreover, sequéis and clear signs of recent selfinjuries were observed in her trunk, forearms and hands. The findings of morbid obesity, anasarca, self-injury, hyperuricemia and hypoxemia in Prader- Willi syndrome are emphasized.

El síndrome de Prader-Willi es un desorden multisistémico infrecuente causado por defectos genéticos del cromosoma 15 (15qll-ql3), debido a deleciones o disomía uniparental. Se caracteriza por hipotonía neonatal, dismorfias faciales, baja estatura, incapacidades motoras y mentales, problemas conductuales, hiperfagia, obesidad precoz e hipogonadismo hipogonadotrófico. Presentamos una mujer de 17 años, con IMC de 74 Kg/m² con diagnóstico genético previo del síndrome que ingresó con anasarca, intensa cianosis, disnea y oliguria. Presentaba elevación plasmática de urea, creatinina y aminotransferasas, asociadas con hiperkalemia e hiperuricemia. Había utilizado regularmente ñuoxetina durante los seis meses precedentes y evolucionó con hipertensión arterial severa e insuficiencia respiratoria, que requirieron de cuidados intensivos. Además, se constataron cicatrices y claras señales de automutilación reciente en su tronco, antebrazos y manos. Se destacan los hallazgos de obesidad mórbida, anasarca, automutilación, hiperuricemia e hipoxemia en el síndrome de Prader-Willi.

Liver and lung metastasis and local lymph node invasion are reported in a 26-year-old Brazilian woman with an asymptomatic colon cancer. She was admitted complaining of right upper quadrant pain, and the diagnostic procedures revealed an unsuspected adenocarcinoma (stage IV) in the descending colon. This malignancy is more frequent in patients older than 40 years, but it usually follows a more aggressive course in young people. Late detection of colon cancer usually results in worst prognosis

Se presenta un caso en que se demuestran metástasis de un cáncer del colon asintomático en hígado y pulmones, además de invasión ¡ocal de ¡infonodos en una mujer brasileña de 26 años de edad. Al ingresar al hospital, la paciente se quejaba de dolor en hipocondrio derecho. Los procedimientos diagnósticos revelaron un adenocarcinoma no sospechado (fase IV) en el colon descendente. Esta malignidad es más frecuente en ¡os pacientes mayores de 40 años, pero suele tener un curso más agresivo en personas jóvenes. La detección tardía del cáncer del colon habitualmente condiciona un peor pronóstico

OBJETIVO: Foram revisados os exames de seriografia do esôfago, estômago e duodeno (SEED), a fim de demonstrar os principais diagnósticos e achados radiológicos, o atual benefício para o paciente e a viabilidade financeira para os serviços de radiologia. MATERIAIS E MÉTODOS: Estudo retrospectivo e descritivo realizado a partir do levantamento dos exames realizados no período de 6/3/2001 a 12/4/2002 no Serviço de Radiologia do Hospital Santa Cruz da Beneficência Portuguesa de Niterói. RESULTADOS: Do total de 270 exames, 115 (42,5%) apresentavam alterações radiológicas (anatômicas, congênitas, adquiridas, funcionais, pépticas ou relacionadas a cirurgias) e 155 (57,5%) exames foram normais. Em relação à faixa etária, 197 (72,9%) eram pacientes de zero a 12 anos incompletos e 73 (27,1%) tinham mais de 12 anos. CONCLUSÃO: A SEED não deve cair em desuso e sim se manter como um importante método complementar para o estudo das doenças do trato gastrintestinal superior, principalmente em crianças e nos casos cirúrgicos, pelo seu indubitável benefício aos pacientes. Assim, devemos ter em mente que o exame contrastado e o exame endoscópico do trato gastrintestinal superior são complementares e não excludentes, quando consideramos as vantagens e as desvantagens de cada método. A SEED é um exame simples, rápido, relativamente barato e com poucos riscos para os pacientes.

OBJECTIVE: To review upper gastrointestinal tract (UGI) contrast examinations in order to establish the main diagnoses and radiological findings, the actual benefits to the patients and the costs for the department of radiology. MATERIALS AND METHODS: This is a retrospective study of 270 UGI contrast examinations performed between 6/3/2001 and 12/4/2002 at the Department of Radiology of "Hospital Santa Cruz/Beneficência Portuguesa de Niterói", Niterói, RJ, Brazil. RESULTS: A total of 270 examinations were reviewed. Radiological findings (anatomical, congenital, acquired, peptic or surgery related findings) were seen in 115 (42.5%) examinations while 155 (57.5%) examinations were normal. The age range was 0-12 years in 197 (72.9%) patients whereas 73 (27.1%) patients were above 12 year-old. CONCLUSION: Due to the clear benefit to the patients, UGI contrast examinations should continue to be used as an important complementary method to study UGI diseases, particularly in children and surgical cases. Therefore, we should keep in mind that UGI contrast examinations and endoscopy are complementary methods of investigation when comparing its advantages and disadvantages. UGI contrast examination is a fast, simple, and relatively low cost procedure. In addition, it presents low risk to the patients.

OBJECTIVE: To analyze the efficacy of percutaneous transluminal septal alcoholization in the treatment of refractory obstructive hypertrophic cardiomyopathy (HOC). METHODS: The patients were referred for alcoholization after Doppler echocardiography. Before and after alcoholization, the intraventricular pressure gradient was recorded. Alcoholization was performed with a 3mL injection of absolute alcohol through a coronary angioplasty balloon catheter. The procedure was concluded after a significant reduction or abolition of the pressure gradient. RESULTS: Of 22 patients, 18 (81.8%) successfully concluded the procedure with a reduction in intraventricular pressure gradient at baseline (from 67.6±24.2 mmHg to 3.8± 1.9 mmHg, p<0.005) and after extrasystole (from 110.4± 24.2 mmHg to 9.6±2.6 mm Hg, p<0.005). A significant reduction in mean interventricular septal thickness (from 2± 0.3 mm to 1.7±0.2 mm, p<0.005) and in peak pressure gradient (from 90.7±23.5 mmHg to 6.1±1.4 mmHg, p<0.005) was observed on Doppler echocardiography after 6 months, when all patients were in functional class I. The most frequent acute complication, present in 11% of the patients, was the need for definitive pacing implantation. Relapse of the symptoms and reappearance of the pressure gradient occurred in 16.6% of the patients. One patient (5.5%) died probably due to a diffuse coronary spasm prior to the procedure, and another died suddenly on late follow-up. CONCLUSION: Percutaneous transluminal septal alcoholization is effective and safe in the treatment of HOC.